Phase II Randomized, Double-Blinded Comparison of a Single High Dose (5×108 TCID50) of Modified Vaccinia Ankara Compared to a Standard Dose (1×108 TCID50) in Healthy Vaccinia-Naïve Individuals
Vaccine - Netherlands
doi 10.1016/j.vaccine.2014.02.043
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 1, 2014
Authors
Publisher
Elsevier BV